Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Cancer Epidemiol. 2015 Jul 9;39(5):752–762. doi: 10.1016/j.canep.2015.06.008

Table II.

Means and standard deviations of plasma carotenoid and tocopherol levels at baseline and at 3-months post-intervention

Baseline Post-intervention (at 3-months)
All subjects (n = 39) Intervention (n = 22) Control (n = 17) P § All subjects (n = 35) Intervention (n = 20) Control (n = 15) P §
Plasma carotenoids and tocopherols (μg/ml) Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
α–tocopherol 14.91 ± 5.15 15.23 ± 5.56 14.51 ± 4.71 0.67 14.35 ± 5.17 14.64 ± 5.48 13.96 ± 4.87 0.71
γ–tocopherol 1.70 ± 1.01 1.67 ± 1.01 1.73 ± 1.04 0.86 1.65 ± 0.99 1.60 ± 0.89 1.70 ± 1.13 0.78
α–carotene 0.04 ± 0.03 0.04 ± 0.03 0.05 ± 0.03 0.60 0.05 ± 0.04 0.04 ± 0.03 0.05 ± 0.05 0.64
cis–β-carotene 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.07 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.32
trans–β-carotene 0.20 ± 0.13 0.18 ± 0.12 0.24 ± 0.15 0.17 0.20 ± 0.14 0.20 ± 0.16 0.21 ± 0.12 0.83
α–cryptoxanthin 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.77 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.86
β–cryptoxanthin 0.11 ± 0.08 0.11 ± 0.09 0.10 ± 0.07 0.71 0.10 ± 0.07 0.10 ± 0.08 0.09 ± 0.06 0.87
lutein 0.11 ± 0.06 0.10 ± 0.06 0.12 ± 0.07 0.40 0.12 ± 0.07 0.12 ± 0.07 0.12 ± 0.08 0.92
zeaxanthin 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.02 0.30 0.03 ± 0.01 0.02 ± 0.01 0.03 ± 0.01 0.47
cis-lutein/zeaxanthin 0.01 ± 0.01 0.01 ± 0.01 0.01 ± 0.01 0.59 0.02 ± 0.01 0.02 ± 0.01 0.01 ± 0.01 0.07
cis-lycopene 0.18 ± 0.13 0.18 ± 0.11 0.18 ± 0.15 0.94 0.17 ± 0.11 0.19 ± 0.10 0.15 ± 0.13 0.26
trans-lycopene 0.19 ± 0.12 0.20 ± 0.11 0.19 ± 0.14 0.81 0.19 ± 0.11 0.22 ± 0.10 0.16 ± 0.12 0.12

Abbreviation: SD, standard deviation

§

P value comparing intervention and control groups based on Student's t-test